Samuel M. Alaish
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samuel M. Alaish has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Abigail E. Martin
324 Colony Blvd, Lexington, KY 40502
1 shared publication - Anthony L. DeRoss
Division of Pediatric General Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, 9500 Euclid Avenue, R3, Cleveland, OH 44195
1 shared publication Bareng A.S. Nonyane
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
1 shared publication- Brian W. Gray
Riley Hospital for Children, Division of Pediatric Surgery, Indiana University School of Mecicine, Indianapolis, IN, USA
1 shared publication Chen-Chih Sun
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
1 shared publication- Christian McEvoy
Department of General Surgery, Naval Medical Center San Diego , San Diego, CA 92134
1 shared publication
Latest Publications
- 17 February 2021
- Published by Taylor & Francis
- p. 88-91
Management of Short Bowel Syndrome After Necrotizing Enterocolitis
Short bowel syndrome is a common complication following lifesaving intestinal resection for NEC and results in an inability of the child to absorb adequate enteral nutrients to sustain growth. The advent of parenteral nutrition in the 1960s changed what was previously a universally fatal diagnosis to a chronic treatable condition, and our understanding of the disease process and management strategies have evolved considerably over the ensuing decades. While parenteral nutrition remains the mainstay of nutritional support in the early stages, the goal of care is to facilitate intestinal adaptation in order to achieve enteral autonomy, while minimizing complications such as intestinal failure–associated liver disease, central line–associated bloodstream infections, intestinal dysbiosis, and sepsis. Early enteral feed initiation with protocolized advancement is critical, and a variety of pharmaceutical and surgical adjunctive therapies are now available to increase the absorptive capacity of the bowel and minimize complications. Multidisciplinary intestinal rehabilitation programs bring together specialists across disciplines to work collaboratively and achieve improved outcomes. As our understanding of the pathophysiology of short bowel syndrome continues to evolve, new therapeutic options, such as drugs targeted to augment intestinal adaptation and tissue-engineered bowel, have tremendous potential to improve outcomes and quality of life for these challenging patients.
- 17 February 2021
- Published by Taylor & Francis
- p. 88-91
Management of Short Bowel Syndrome After Necrotizing Enterocolitis
Short bowel syndrome is a common complication following lifesaving intestinal resection for NEC and results in an inability of the child to absorb adequate enteral nutrients to sustain growth. The advent of parenteral nutrition in the 1960s changed what was previously a universally fatal diagnosis to a chronic treatable condition, and our understanding of the disease process and management strategies have evolved considerably over the ensuing decades. While parenteral nutrition remains the mainstay of nutritional support in the early stages, the goal of care is to facilitate intestinal adaptation in order to achieve enteral autonomy, while minimizing complications such as intestinal failure–associated liver disease, central line–associated bloodstream infections, intestinal dysbiosis, and sepsis. Early enteral feed initiation with protocolized advancement is critical, and a variety of pharmaceutical and surgical adjunctive therapies are now available to increase the absorptive capacity of the bowel and minimize complications. Multidisciplinary intestinal rehabilitation programs bring together specialists across disciplines to work collaboratively and achieve improved outcomes. As our understanding of the pathophysiology of short bowel syndrome continues to evolve, new therapeutic options, such as drugs targeted to augment intestinal adaptation and tissue-engineered bowel, have tremendous potential to improve outcomes and quality of life for these challenging patients.
- 1 April 2018
- Published by Elsevier in The Journal of Pediatrics
- Vol. 195, 140-147.e1
Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure–Associated Liver Disease in Surgical Infants
- 1 April 2018
- Published by Elsevier in The Journal of Pediatrics
- Vol. 195, 140-147.e1
Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure–Associated Liver Disease in Surgical Infants
- 1 March 2009
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 44 (3) , e11-e14
Intraabdominal pulmonary sequestration presenting with elevated urinary normetanephrine levels
- 1 March 2009
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 44 (3) , e11-e14
Intraabdominal pulmonary sequestration presenting with elevated urinary normetanephrine levels